Pear tree root cancer prevention

(1) Test materials: The oligochitosan citrate calli “Magic Formula 1” produced by Dalian Baoluobao Marine Life Sciences Research and Development Center Co., Ltd., and the seaweed extract plant immunopotentiation opsonization carboxymethyl chitosan The protective agent and other auxiliary drugs introduced by the company will disinfect the fugitive and antibacterial agent “402”. (2) The technical program The period of prevention and cure: The symptoms before colonization: There is no obvious symptom, but the Agrobacterium tumefaciens will infect the plants from the root trauma of the graft and the graft interface. Control methods: before planting with chitosan citrate 500 times the calli agent + seaweed plant immune response opsonization 1000 times + antibacterial agent "402" 800 times the mixture, concentrated seedlings soaked for 6 hours. Period of prevention and treatment: after colonization, the disease manifestations: mainly occur in the root and neck, but also in the lateral and branch roots, the tumor is mostly semi-circular or nearly semi-circular, the tumor is large and hard, lignification, milky or slightly reddish at birth, smooth , soft, after gradually becoming brown and dark brown, rough or uneven surface. Control methods: first spread the topsoil of the tree tray, expose the roots of the trees, remove the tumors with a sharp knife, and use the seaweed extract to increase the production of opsonization chemicals 1000 times + disinfectant or antibacterial agent "402" 800 times the mixture; Gradually, the chitosan citrate callus 500 times and the carboxymethyl chitosan 50 times were applied. After 3 to 4 days of control, seaweed extracts were boosted by 1000-times immunomodulatory factor and 1000-times chitosan citrate callus mixed solution. The water was leached and the soil was sealed. The scraped root cancer lesions were burned cleanly. (3) Pilot plant sites: Qiangceng Agricultural Science and Technology Park, Ganjingzi District, Dalian, and Jinzhou District, Dalian, to the outward-oriented modern agricultural park. (4) Demonstration scale: 100 hectares

Rabies Vaccine (Vero Cell) for Human Use


The first company develops and employs the technology of microcarrier bioreactor for production of Rabies Vaccine (Vero Cell) for Human Use in China. The culturing process has good repeatability, the product shows reliable quality and in reasonable stability and has the comparable effect with lyophilized formulation.

Rabies Vaccine


Finished Products

Rabies Vaccine,Freeze-Dried Rabies Vaccine,Mild Rabies Vaccine,Stable Rabies Vaccine For Human Use

Changchun BCHT Biotechnology Co. , http://www.ccbcht.com